NCT02632123View on ClinicalTrials.gov

Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis

CompletedOBSERVATIONAL
Enrollment

260

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Idiopathic Pulmonary Fibrosis
Trial Locations (2)

N6A 5W9

London Health Science Centre, London

00133

Policlinico Tor Vergata, Rome

All Listed Sponsors
collaborator

Western University, Canada

OTHER

collaborator

Università degli studi di Roma Tor Vergata

UNKNOWN

collaborator

University of Waterloo

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02632123 - Validation of the Risk Stratification Score in Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter